Isatuximab plus pomalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma (RRMM) in real-life context: interim analysis of the retrospective IMAGE study - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2022
Fichier non déposé

Dates et versions

hal-04071537 , version 1 (17-04-2023)

Identifiants

  • HAL Id : hal-04071537 , version 1

Citer

Xavier Leleu, Radhia Lafore, Daniel Iaquinta, Christina Tekle, Megan Rice, et al.. Isatuximab plus pomalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma (RRMM) in real-life context: interim analysis of the retrospective IMAGE study. 64th ASH Annual Meeting and Exposition, Dec 2022, New Orleans, United States. ⟨hal-04071537⟩
8 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More